NASDAQ · LENZ
LENZ Therapeutics, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for LENZ has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Dec 2026 | $-0.86 | $-0.69 | $-1.00 | 4 |
| Mar 2027 | $-0.76 | $-0.76 | $-0.76 | 1 |
| Jun 2027 | $-0.68 | $-0.68 | $-0.68 | 1 |
| Sep 2027 | $-0.61 | $-0.61 | $-0.61 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · The Motley Fool · MarketBeat · BNK Invest- Zacks · Oct 28, 4:45 PM EDTLENZ Therapeutics, Inc. (LENZ) Reports Q3 Loss, Misses Revenue EstimatesLENZ Therapeutics, Inc. (LENZ) delivered earnings and revenue surprises of -2.06% and -15.67%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Oct 23, 9:00 AM EDTRegeneron (REGN) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseRegeneron (REGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- The Motley Fool · Aug 19, 9:55 AM EDTLENZ Therapeutics (LENZ) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 11, 7:04 PM EDTLENZ Therapeutics Q2 Earnings Call HighlightsLENZ Therapeutics (NASDAQ:LENZ) reported second-quarter revenue of $5.5 million as it continued the commercial launch of VIZZ, citing modest quarterly growth and a pickup in prescription activity following the July rollout of national television advertising and a telehealth acces
- Zacks · Aug 11, 5:25 PM EDTLENZ Therapeutics, Inc. (LENZ) Reports Q2 Loss, Beats Revenue EstimatesLENZ Therapeutics, Inc. (LENZ) delivered earnings and revenue surprises of +15.70% and +148.24%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 6, 9:50 AM EDTCG Oncology, Inc. (CGON) Reports Q2 Loss, Misses Revenue EstimatesCG Oncology, Inc. (CGON) delivered earnings and revenue surprises of -28.57% and -59.02%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 23, 10:00 AM EDTAlnylam Pharmaceuticals (ALNY) Reports Next Week: Wall Street Expects Earnings GrowthAlnylam (ALNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Jul 22, 10:00 AM EDTEarnings Preview: LENZ Therapeutics, Inc. (LENZ) Q2 Earnings Expected to DeclineLENZ Therapeutics, Inc. (LENZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- BNK Invest · Jul 14, 4:39 PM EDTOversold Conditions For Lenz Therapeutics (LENZ)Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
- RTTNews · Jun 25, 5:30 AM EDTLENZ Therapeutics And Arrotex Partner To Commercialize VIZZ In Australia And New Zealand(RTTNews) – LENZ Therapeutics, Inc. (LENZ) has entered into an exclusive license and commercialization agreement with Arrotex Pharmaceuticals Pty Ltd. to register and market VIZZ, its aceclidine ophthalmic solution for presbyopia in Australia and New Zealand.
- RTTNews · Jun 12, 11:36 AM EDTWeekly Buzz: GH, LLY Gain FDA Nod; TEVA, GSK, Lead M&A Wave; ZEAL, LLY Post Strong Data(RTTNews) – This week, the biotech sector saw a surge of FDA, EU, and China approvals spanning oncology, dermatology, autoimmune and rare disease indications. Strategic acquisitions and licensing deals drove pipeline expansion, while positive clinical readouts in obesity, MASLD,
- RTTNews · Jun 8, 3:50 AM EDTEverest Medicines Acquires Rights To Develop And Commercialize VIZZ In Greater China(RTTNews) – LENZ Therapeutics, Inc. (LENZ), a pharmaceutical company focused on ophthalmic treatments, announced that Everest Medicines (HKEX:1952) has acquired rights to develop, manufacture and commercialize VIZZ in Greater China, including mainland China, Hong Kong, SAR, Macao
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for LENZ Therapeutics, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.